Ryan Ross

Mr. Ryan Ross

Department of Biostatistics, School of Public Health, University of Michigan

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2020 in Academic Emergency Medicine
Verified
Journal Article
Closed access
PDF file
RSRachel E. Solnick
Rachel E. Solnick
GCGrace Chao
Grace Chao
RRRyan Ross
Ryan Ross
GKGordon T. Kraft‐Todd
Gordon T. Kraft‐Todd
KKKeith E. Kocher
Keith E. Kocher

20 October 2020 in Health Services and Outcomes Research Methodology
Verified
Journal Article
Closed access
PDF file
RRRyan Ross
Ryan Ross
XSXu Shi
Xu Shi
MCMegan E. V. Caram
Megan E. V. Caram
PTPhoebe A. Tsao
Phoebe A. Tsao
PLPaul Lin
Paul Lin
BMBhramar Mukherjee
Bhramar Mukherjee

24 July 2026 in Journal of Pain and Symptom Management
Verified
Journal Article
Closed access
HRHari S. Raman
Hari S. Raman
EPElizabeth Packnett
Elizabeth Packnett
EBEdo Banach
Edo Banach
RRRyan Ross
Ryan Ross
TLTarne Lamp
Tarne Lamp
OOOreofe O. Odejide
Oreofe O. Odejide

24 June 2020 in Preprints.org
Verified
Preprint
Open access
PDF file
RRRyan Ross
Ryan Ross
XSXu Shi
Xu Shi
MCMegan Caram
Megan Caram
PTPheobe Tsao
Pheobe Tsao
PLPaul Lin
Paul Lin
BMBhramar Mukherjee
Bhramar Mukherjee
Medical insurance claims are becoming increasingly common data sources to answer a variety of questions in biomedical research. Although comprehensive in terms of longitudinal characterization of disease development and progression for a potentially large number of patients, population-based studies using these datasets require thoughtful modification to sample selection and analytic strategies, relative to other types of studies. Along with complex selection bias and missing data issues, claims-based studies are purely observational, which limits effective understanding and characterization of the treatment differences between groups being compared. All these issues contribute to a crisis in reproducibility and replication of comparative findings. This paper offers some practical guidance to the full analytical process, demonstrates methods for estimating causal treatment effects on several types of outcomes common to such studies, such as binary, count, time to event and longitudinally varying repeated measures outcomes, and aims to increase transparency and reproducibility. We provide an online version of the paper with readily implementable code for the entire analysis pipeline to serve as a guided tutorial for practitioners. The online version can be accessed at https://rydaro.github.io/. The analytic pipeline is illustrated using a sub-cohort of patients with advanced prostate cancer from the large Clinformatics TM Data Mart Database (OptumInsight, Eden Prairie, Minnesota), consisting of 73 million distinct private payer insurees from 2001-2016.

21 April 2026 in Journal of Occupational and Environmental Medicine
Verified
Journal Article
Open access
OVOralee J. Varnado
Oralee J. Varnado
BLBirong Liao
Birong Liao
MJMichelle Jerry
Michelle Jerry
CLCarolyn R. Lew
Carolyn R. Lew
RRRyan Ross
Ryan Ross
SSShraddha Shinde
Shraddha Shinde
Objectives: The aim of this study was to examine work loss, motor vehicle accidents, and serious injuries among patients with obstructive sleep apnea (OSA) and obesity (“patients”) versus matched controls without OSA or obesity (“controls”). Methods: Outcomes were compared for patients and controls after matching on baseline demographics, overall and stratified by OSA severity. Results: Patients were 3 times more likely to have a short-term disability (STD) claim (15.7% vs 5.0%, P < 0.001) and had higher STD costs ($960 vs $305, P < 0.001) than matched controls. The prevalence of serious injuries was twofold higher (17.1% vs 8.4%; P < 0.001). Conclusions: Patients with OSA and obesity have an elevated risk of STD and serious injuries versus matched controls. Both weight and OSA management have the potential to reduce the burden of OSA and thus have the potential to reduce the burden of STD and serious injuries.

30 March 2026 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
OHOscar Herrera-Restrepo
Oscar Herrera-Restrepo
EPElizabeth Packnett
Elizabeth Packnett
MRMegan K Richards
Megan K Richards
EKElise Kuylen
Elise Kuylen
OOOluwatosin Olaiya
Oluwatosin Olaiya
AAAndrew G Allmon
Andrew G Allmon
Background: Invasive meningococcal disease (IMD) is associated with high case-fatality rates and severe long-term sequelae. In the United States (US), IMD incidence rate (IR) is highest among infants aged <1 year, with most cases occurring in infants aged <6 months. This study estimated IMD incidence in commercially and Medicaid-insured infants, toddlers, and children aged <11 years. Methods: This retrospective claims analysis utilized real-world data (01 January 2005 to 31 December 2022) from the MarketScan® Commercial and Multi-State Medicaid Research Databases of infants (aged <1 year), toddlers (aged 1–4 years), and children (aged 5–10 years). IMD incidence, time at risk for IMD, IR, and IR ratio (IRR) were evaluated overall and by demographic/clinical characteristics. Results: Within the commercially and Medicaid-insured cohorts, 21 and 115 infants, 34 and 80 toddlers, and 36 and 37 children with IMD were identified, respectively. Overall IMD IRs in infants, toddlers, and children were 0.45, 0.17, and 0.11 per 100 000 person-years (PY; commercially insured) and 1.97, 0.45, and 0.18 per 100 000 PY (Medicaid-insured), respectively. Incidence rates were highest in infants aged <4 months (1.03 and 4.65 per 100 000 PY for infants aged 2 to <3 months [commercially insured] and 1 to <2 months [Medicaid-insured], respectively). Significantly elevated IRRs were observed among infants and children with specific demographic and clinical characteristics, including residence in rural counties, immunocompromised status, and complement component deficiency. Conclusions: IMD incidence is low in the United States, but varies by age, insurance type, and demographic/clinical characteristics. Timely preventative interventions, such as early vaccination, may reduce the incidence, risk, and associated burden of IMD.